-
. Klaas Nico Faber, University Medical Center Groningen. The research project aims at developing innovative cell-selective delivery strategies for nanoparticles to fibroblasts and macrophages
-
(GRIP) is part of the Faculty of Science and Engineering (FSE) of the University of Groningen and collaborates closely with the University Medical Center Groningen (UMCG). The pharmaceutical and medical
-
at the Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen and Prof. dr. Klaas Nico Faber, University Medical Center Groningen. The research project aims
-
://www.rug.nl/gbb ). The PhD study entails a close collaboration with Dr J.R. Prins part of the reproductive immunology group at the University Medical Centre Groningen. The successful applicant will work on a
-
Center Groningen (UMCG). The pharmaceutical and medical research within GRIP and the UMCG is very multidisciplinary. This project aims to develop light-activation processes for the emerging field of time
-
closely with the University Medical Center Groningen (UMCG). The pharmaceutical and medical research within GRIP and the UMCG is very multidisciplinary. This project aims to develop light-activation
-
J.R. Prins part of the reproductive immunology group at the University Medical Centre Groningen. The successful applicant will work on a multidisciplinary project aimed at developing a prognostic test